NASDAQ:ENLV
Enlivex Therapeutics Ltd.
- Stock
Last Close
1.26
08/11 21:00
Market Cap
29.22M
Beta: 0.61
Volume Today
92.19K
Avg: 34.86K
PE Ratio
−1.87
PFCF: −1.95
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 2.28M - | |||||||||||
cost of revenue | 297K - | 286K 3.70% | 546K 90.91% | 777K 42.31% | 835K 7.46% | |||||||
gross profit | -297K - | 1.99M 770.37% | -546K 127.42% | -777K 42.31% | -835K 7.46% | |||||||
selling and marketing expenses | 829K - | 479K - | ||||||||||
general and administrative expenses | 416K - | 2.64M 534.38% | 6.95M 163.47% | 6.99M 0.46% | 2.96M 57.64% | 937K 68.33% | 2.75M 193.49% | 3.60M 30.98% | 6.24M 73.24% | 6.70M 7.40% | ||
selling general and administrative expenses | 416K - | 2.64M 534.38% | 7.78M 194.88% | 6.99M 10.24% | 3.44M 50.78% | 937K 72.75% | 2.75M 193.49% | 3.60M 30.98% | 6.24M 73.24% | 6.70M 7.40% | 6.11M 8.89% | |
research and development expenses | 732K - | 4.44M 506.69% | 7.69M 73.25% | 8.88M 15.43% | 2.52M 71.66% | 4.25M 69.05% | 5.72M 34.52% | 6.09M 6.32% | 12.88M 111.65% | 18.69M 45.12% | 17.99M 3.78% | |
other expenses | 145K - | 97K 33.10% | 167K 72.16% | 402K 140.72% | ||||||||
cost and expenses | 1.15M - | 7.08M 516.72% | 15.48M 118.59% | 15.87M 2.52% | 5.96M 62.47% | 5.30M 11.02% | 8.62M 62.65% | 9.79M 13.53% | 19.29M 97.12% | 25.80M 33.75% | 24.93M 3.37% | |
operating expenses | 1.15M - | 7.08M 516.72% | 15.48M 118.59% | 15.87M 2.52% | 5.96M 62.47% | 5.30M 11.02% | 8.62M 62.65% | 9.79M 13.53% | 19.29M 97.12% | 25.80M 33.75% | 24.09M 6.61% | |
interest expense | 2K - | 7.00K - | 6.00K 14.29% | 328K 5,366.67% | 5.26M 1,504.57% | 14K 99.73% | ||||||
ebitda | -1.14M - | -7.08M 518.99% | -15.46M 118.50% | -15.83M 2.39% | -5.89M 62.76% | -6.10M 3.48% | -7.42M 21.59% | -7.24M 2.37% | -23.77M 228.27% | -18.94M 20.34% | -24.09M 27.23% | |
operating income | -1.15M - | -7.08M 516.72% | -15.48M 118.59% | -15.87M 2.52% | -5.96M 62.47% | -5.30M 11.02% | -8.62M 62.65% | -9.79M 13.53% | -19.29M 97.12% | -25.80M 33.75% | -24.93M 3.37% | |
depreciation and amortization | 5K - | 5K 0% | 17K 240% | 38K 123.53% | 64K 68.42% | 121K 89.06% | 1.20M 893.39% | 2.54M 111.65% | -4.48M 276.18% | 6.86M 253.08% | 835K 87.83% | |
total other income expenses net | 5K - | 58K 1,060% | 135K 132.76% | 60K 55.56% | 4K 93.33% | 922K 22,950% | -765K 182.97% | -2.04M 166.54% | 4.82M 336.39% | -5.26M 209.19% | -4.14M 21.34% | |
income before tax | -1.15M - | -7.02M 513.28% | -15.34M 118.47% | -15.81M 3.03% | -5.92M 62.56% | -4.24M 28.31% | -9.38M 121.22% | -11.82M 26.00% | -14.47M 22.36% | -31.06M 114.68% | -29.07M 6.41% | |
income tax expense | 2K - | 24K - | 216K 800% | 28K 87.04% | 1.06M 3,675% | 765K 27.63% | 2.04M 166.54% | -4.82M 336.39% | 11.35M 335.41% | |||
net income | -1.15M - | -7.02M 513.28% | -15.37M 118.81% | -16.02M 4.28% | -5.95M 62.89% | -4.24M 28.65% | -10.15M 139.25% | -13.86M 36.59% | -9.65M 30.40% | -42.41M 339.54% | -29.07M 31.45% | |
weighted average shs out | 271.85K - | 306.49K 12.74% | 355.76K 16.08% | 397.65K 11.78% | 414.20K 4.16% | 3.51M 747.25% | 8.65M 146.47% | 13.17M 52.25% | 17.86M 35.62% | 18.39M 3.00% | 18.57M 0.98% | |
weighted average shs out dil | 271.85K - | 306.49K 12.74% | 355.76K 16.08% | 397.65K 11.78% | 428.24K 7.69% | 3.51M 719.48% | 8.65M 146.47% | 13.17M 52.25% | 17.86M 35.62% | 18.39M 3.00% | 18.57M 0.98% | |
eps | -4.21 - | -22.91 444.18% | -43.19 88.52% | -40.29 6.71% | -13.88 65.55% | -1.21 91.28% | -1.17 3.31% | -1.05 10.26% | -0.54 48.57% | -2.31 327.78% | -1.56 32.47% | |
epsdiluted | -4.21 - | -22.91 444.18% | -43.19 88.52% | -40.29 6.71% | -13.88 65.55% | -1.21 91.28% | -1.17 3.31% | -1.05 10.26% | -0.54 48.57% | -2.31 327.78% | -1.56 32.47% |
All numbers in USD (except ratios and percentages)